This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
After communicating with the FDA about font sizes for potential packaging on its...
Sanofi is harnessing the power of pop music to boost awareness of the experience...
Six years after being spun out from Novartis and becoming a public company, eye ...
COVID-19 tweets from November 2020 have come back to haunt Pfizer once again. Fo...
New Jersey-based AACE Pharmaceuticals has been slammed in an FDA warning letter ...
Some two weeks after the public comment period closed for the Trump administrati...
After Merck paid a hefty sum to co-develop and co-commercialize HER3-DXd, the dr...
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...
After a fourth quarter in which revenue boomed throughout the biopharma industry...
Alnylam Pharmaceuticals has put its dancing shoes on to raise awareness of the e...
Alnylam Pharmaceuticals has put its dancing shoes on to raise awareness of the e...
While the Trump administration’s threat of pharmaceutical import tariffs and mos...
A month after the FDA lifted its clinical hold on GSK’s vaginal yeast infection ...
Novartis was locked in a heated bidding war with another interested party for we...
An independent data monitoring committee assessing a phase 3 trial for InflaRx's...
Sanofi and the Vietnam Vaccine Company (VNVC) have kicked off a vaccine producti...
The CDC's recommended immunization schedule no longer includes COVID vaccines fo...
Europe’s Committee for Medicinal Products for Human Use has recommended GSK's Bl...
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...
The layoffs at Allergan's Irvine, California, headquarters are effective on July...
After a fourth quarter in which revenue boomed throughout the biopharma industry...
Sanofi’s sponsorship of the Olympics and Paralympics has led to a breach of the ...
As it works to send opioid use disorder treatment Sublocade back into its prior ...
The FDA has slapped Savara with a refuse to file letter after the biotech in Mar...